Healthy Aging & Longevity Venture Studio

The Healthy Aging & Longevity Venture Studio is a 9-month immersive programme designed to scale the next generation of solutions for chronic population health and climate-linked health outcomes.

We support 20 high-potential ventures through tailored venture-building support, global residency, and access to MRI’s unparalleled research, capital, and commercialisation network.

Fellows and Innovators-in-Residence work from global hubs with customised roadmaps toward real-world deployment and investment-readiness.
Header image

Application tracks

There are 2 application tracks. Please see and apply that is most relevant to you.

R&D Innovation Track

- Access to MRI Research Lab facilities or affiliated Innovation Studies
- Global R&D Hub Exchange Program incl. travel stipend
- Impact KPI Delivery
- Investment Module
- Thought Leadership-Investor Roundtables

Commercialisation Track

- Artificial Intelligence, Tech, Robotics & Data Analytics
- R&D Legal and Negotiations
- GTM Effectiveness with exited founders/investors
- Pilot Partnerships for revenue generation
- Investor Showcase and 1-2-1 Connection

Success metrics

Our success metrics encompass various aspects, focusing on the outcomes, achievements, and milestones attained throughout the immersive 9-month program.
Impact KPIs that demonstrate improved early detection for chronic Pop Health conditions
Impact KPIs measuring improved Climate impact/output directly +ve for Human Health
Pilot success
Capital closed

Deliverable Options

These deliverable options are designed to provide tangible outputs that demonstrate the progress and impact of the ventures throughout the program.
Research Publication and/or
Tech Module/Application

Application Process

The following criteria outline the key requirements for ventures seeking to participate in the program

Focus areas

Researcher or Venture in MRI areas of Preventative Health for chronic population health conditions (incl. Climate impact on Health – Built Environment, Marine BioTech)

Traction

Demonstrated R&D or Commercial traction

Growth stage

Pre-Seed to Series A

Legal domicile

U.S., UK, or acceptable [off-shore jurisdiction]

Discretion

MRI maintain discretion on successful applicants

Sponsorship

Funding Options include sponsorship

Application timelines

These deliverable options are designed to provide tangible outputs that demonstrate the progress and impact of the ventures throughout the program.
Open: 25th July, 2025
Close: 05th September, 2025